Difficulty: Medium
Average Score: 78%
Practice
You are discussing with medical students the role of chemotherapy in malignant germ cell tumors (GCTs); you state that GCTs are sensitive to some types of chemotherapy. Of the following, the MOST effective chemotherapeutic agent in GCTs is
Correct answer
C
Rationale
In the treatment of malignant germ cell tumors (GCTs), cisplatin is the most effective chemotherapeutic agent. This is because cisplatin is a platinum-based chemotherapy drug that has shown high efficacy in treating GCTs by disrupting DNA synthesis in rapidly dividing cancer cells, leading to cell death.
Vincristine (Option A) is not as effective in GCTs compared to cisplatin, as it primarily acts by disrupting microtubule function and is more commonly used in other types of cancers. Cyclophosphamide (Option B) is an alkylating agent that is less specific to GCTs and is not considered the first-line treatment for this type of cancer. Methotrexate (Option D) is a folate antagonist that is also not as effective as cisplatin in treating GCTs.
In an educational context, it is important for medical students to understand the mechanism of action of different chemotherapeutic agents and their specific applications in various types of cancers. Understanding the rationale behind choosing cisplatin over other agents for treating GCTs helps students grasp the principles of personalized medicine and evidence-based practice in oncology.
Vincristine (Option A) is not as effective in GCTs compared to cisplatin, as it primarily acts by disrupting microtubule function and is more commonly used in other types of cancers. Cyclophosphamide (Option B) is an alkylating agent that is less specific to GCTs and is not considered the first-line treatment for this type of cancer. Methotrexate (Option D) is a folate antagonist that is also not as effective as cisplatin in treating GCTs.
In an educational context, it is important for medical students to understand the mechanism of action of different chemotherapeutic agents and their specific applications in various types of cancers. Understanding the rationale behind choosing cisplatin over other agents for treating GCTs helps students grasp the principles of personalized medicine and evidence-based practice in oncology.